Goldman Sachs’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.89M | Sell |
310,728
-174,838
| -36% | -$2.83M | ﹤0.01% | 3538 |
|
|
2025
Q4 | $8.49M | Sell |
485,566
-11,981
| -2% | -$225K | ﹤0.01% | 3256 |
|
|
2025
Q3 | $10.3M | Buy |
497,547
+194,121
| +64% | +$4.71M | ﹤0.01% | 2933 |
|
|
2025
Q2 | $6.46M | Sell |
303,426
-269,365
| -47% | -$6.14M | ﹤0.01% | 3170 |
|
|
2025
Q1 | $11M | Sell |
572,791
-337,211
| -37% | -$6.76M | ﹤0.01% | 2607 |
|
|
2024
Q4 | $16.2M | Buy |
910,002
+414,647
| +84% | +$8.04M | ﹤0.01% | 2335 |
|
|
2024
Q3 | $10.8M | Buy |
495,355
+41,411
| +9% | +$579K | ﹤0.01% | 2627 |
|
|
2024
Q2 | $3.54M | Sell |
453,944
-226,657
| -33% | -$1.22M | ﹤0.01% | 3476 |
|
|
2024
Q1 | $2.82M | Buy |
680,601
+486,193
| +250% | +$1.93M | ﹤0.01% | 3600 |
|
|
2023
Q4 | $507K | Buy |
194,408
+2,210
| +1% | +$4.55K | ﹤0.01% | 4748 |
|
|
2023
Q3 | $359K | Sell |
192,198
-158,804
| -45% | -$303K | ﹤0.01% | 4809 |
|
|
2023
Q2 | $881K | Sell |
351,002
-89,887
| -20% | -$164K | ﹤0.01% | 4437 |
|
|
2023
Q1 | $772K | Buy |
440,889
+385,378
| +694% | +$1.05M | ﹤0.01% | 4573 |
|
|
2022
Q4 | $236K | Sell |
55,511
-5,229
| -9% | -$9.51K | ﹤0.01% | 5243 |
|
|
2022
Q3 | $72K | Buy |
60,740
+26,347
| +77% | +$29.8K | ﹤0.01% | 5755 |
|
|
2022
Q2 | $34K | Sell |
34,393
-2,384
| -6% | -$3.34K | ﹤0.01% | 6098 |
|
|
2022
Q1 | $90K | Sell |
36,777
-10,313
| -22% | -$26K | ﹤0.01% | 6138 |
|
|
2021
Q4 | $126K | Buy |
47,090
+5,536
| +13% | +$26.6K | ﹤0.01% | 6069 |
|
|
2021
Q3 | $208K | Buy |
41,554
+865
| +2% | +$6.21K | ﹤0.01% | 5703 |
|
|
2021
Q2 | $304K | Sell |
40,689
-45,820
| -53% | -$301K | ﹤0.01% | 5519 |
|
|
2021
Q1 | $508K | Buy |
86,509
+51,700
| +149% | +$334K | ﹤0.01% | 5106 |
|
|
2020
Q4 | $164K | Buy |
+34,809
| New | +$147K | ﹤0.01% | 5160 |
|
Other funds holding SMMT
BBA
VCM
VPM
